Cathie Wood’s ARK Invest has made some recent moves in its portfolio, buying shares of Trade Desk and CRISPR stock while selling Unity.
Trade Desk is a technology company that specializes in digital advertising. ARK Invest’s decision to invest in Trade Desk could be seen as a bet on the future of online advertising, as more companies shift their marketing efforts to digital platforms.
CRISPR stock, on the other hand, belongs to a biotech company that focuses on gene editing technology. This investment by ARK Invest shows their confidence in the potential of CRISPR technology to revolutionize the healthcare industry.
As for the decision to sell Unity, a gaming software company, it is unclear what prompted this move. It could be a strategic decision to reallocate funds to other more promising opportunities in the market.
Overall, Cathie Wood’s ARK Invest continues to make bold and strategic moves in its portfolio, betting on the growth potential of companies like Trade Desk and CRISPR stock while making calculated decisions to sell off holdings like Unity.